Notes
1 The use of trade names is for product identification purposes only and does not imply endorsement.
References
Siddiqui MAA, Perry CM, Scott LJ. Topical methyl aminolevulinate. Am J Clin Dermatol 2004; 5(2): 127–37
Braathen LR. Topical methyl aminolevulinate: a viewpoint. Am J Clin Dermatol 2004; 5(2): 138
Rhodes LE. Topical methyl aminolevulinate: a viewpoint. Am J Clin Dermatol 2004; 5(2): 139–40
Ormrod D, Jarvis B. Topical aminolevulinic acid HC1 photodynamic therapy. Am J Clin Dermatol 2000; 1(2): 133–41
Gaullier JM, Berg K, Peng Q, et al. Use of 5-aminolevulinic acid esters to improve photodynamic therapy on cells in culture. Cancer Res 1997; 57(8): 1481–6
Braathen L, Paredes B, Frolich K, et al. A dose finding study of photodynamic therapy (PDT) with Metvix in actinic keratosis (AK) [abstract no. W24-03]. J Eur Acad Dermatol Venereol 2000; 14 Suppl. 1: 38
Basset-Seguin N, Bachmann Y, Pavel S, et al. A dose finding study of photodynamic therapy with Metvix in patients with basal cell carcinoma [abstract]. J Eur Acad Dermatol Venereol 2000; 14 Suppl. 1: 39
Pariser DM, Lowe NJ, Stewart DM, et al. Photodynamic therapy with topical methyl aminolevulinate for actinic keratosis: results of a prospective randomized multicenter trial. J Am Acad Dermatol 2003 Feb; 48 Suppl. 2: 227–32
Szeimies RM, Karrer S, Radakovic-Fijan S, et al. Photodynamic therapy using topical methyl 5-aminolevulinate compared with cry-otherapy for actinic keratosis: a prospective, randomized study. J Am Acad Dermatol 2002 Aug; 47(2): 258–62
Freeman M, Vinciullo C, Francis D, et al. A comparison of photo-dynamic therapy using topical methyl aminolevulinate (Metvix) with single cycle cryotherapy in patients with actinic keratosis: a prospective, randomized study. J Dermatol Treat 2003; 14(2): 99–106
Foley P, Freeman M, Siller G, et al. A phase III randomized study comparing photodynamic therapy (PDT) using methyl aminolevulinate or placebo cream in nodular basal cell carcinoma (nBCC) [abstract no. P9.14]. 12th Annual Congress of the European Academay of Dermatology and Venereology; 2003 Oct 15–18; Barcelona
Tope WD, Menter A, El-Azhary RA, et al. Comparison of topical methylaminolevulinate photodynamic therapy versus placebo photodynamic therapy in nodular basal cell carcinoma [abstract no. P477]. J Am Acad Dermatol 2004; 50(3 Suppl. ): P123
Basset-Seguin N, Ibbotson S, Emtestam L, et al. Photodynamic therapy using Metvix is as efficacious as cryotherapy in BCC, with better cosmetic results [poster]. 10th Congress of the European Academy of Dermatology and Venereology; 2001 Oct 10–14; Munich
Rhodes LE, de Rie M, Enström Y, et al. Photodynamic therapy using topical methyl aminolevulinate vs surgery for nodular basal cell carcinoma: results of a multicenter randomized prospective trial. Arch Dermatol 2004; 140(1): 17–23
Horn M, Wolf P, Wulf HC, et al. Topical methyl aminolevulinate photodynamic therapy in patients with basal cell carcinoma prone to complications and poor cosmetic outcome with conventional treatment. Br J Dermatol 2003; 149(6): 1242–9
Viniciullo C, Elliott T, Gebauer K, et al. Photodynamic therapy using methyl aminolevulinate in patients with basal cell carcinoma [abstract no. P478]. J Am Acad Dermatol 2004; 50(3 Suppl. ): P124
Rights and permissions
About this article
Cite this article
Topical methyl aminolevulinate: profile report. Drugs Ther. Perspect 20, 6–8 (2004). https://doi.org/10.2165/00042310-200420110-00002
Published:
Issue Date:
DOI: https://doi.org/10.2165/00042310-200420110-00002